Carregant...
Evaluation of anti-tumorigenic activity of BP3B against colon cancer with patient-derived tumor xenograft model
BACKGROUND: KIOM-CRC#BP3B (BP3B) is a novel herbal prescription that is composed of three plant extracts. Our preliminary study identified that BP3B exhibited potent anti-proliferative activity against various types of cancer cell lines in vitro. Because the in vivo anti-tumor effect of BP3B is not...
Guardat en:
| Publicat a: | BMC Complement Altern Med |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5116142/ https://ncbi.nlm.nih.gov/pubmed/27863496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12906-016-1447-8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|